Insights and Qualitative Research
Identify concerns and drive strategic improvements with error data and industry-leading expertise.
Enhancing safety through expert collaboration
Med Safety Board's (MSB's) approach ensures safety concerns are detected and addressed faster and more efficiently, delivering better outcomes for patients and healthcare providers. By convening key product users and medication safety experts to form focus groups, MSB can help you gather insight, validate best practices, and develop strategies for improving safety in both new and established pharmaceutical products and medication-related devices.
Data-driven insights you can trust
The Institute for Safe Medication Practices' National Medication Error Reporting Program (ISMP MERP), ECRI' adverse event database, and the Food and Drug Administration's medication and device adverse databases (FAERS, MAUDE) provide MSB with access to extensive invaluable, independent data. Expert analysis of this data provides insight into patterns of error and its underlying causes to help you identify safety risks before they occur.
Get insight from end users and safety experts to identify concerns, analyze error reports, and develop strategies for enhancing safety in pharmaceutical products and devices
Get in Touch
Let's start zeroing in on exactly how we can help.
More Ways We Help
Pre-Market and In-Market Regulatory Support
Streamline regulatory submissions with expert guidance on FDA approvals, device labeling, risk assessments, and tailored compliance support.
Learn More